Yüklüyor......
Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema
BACKGROUND/AIMS: Bevacizumab and ranibizumab are routinely used to treat diabetic macular edema (DME). We aim to evaluate the usefulness of switching to ranibizumab therapy following bevacizumab treatment failure in eyes with DME. METHODS: We performed a retrospective analysis of a consecutive group...
Kaydedildi:
| Yayımlandı: | Case Rep Ophthalmol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
S. Karger AG
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4357677/ https://ncbi.nlm.nih.gov/pubmed/25802504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000375230 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|